Tech Company Financing Transactions
Tyrogenex Funding Round
On 2/29/2016, Tyrogenex raised $544 thousand in financing from private investors.
Transaction Overview
Company Name
Announced On
2/29/2016
Transaction Type
Venture Equity
Amount
$543,952
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 18 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
197 1st Ave. 330
Needham Heights, MA 02494
USA
Needham Heights, MA 02494
USA
Phone
Website
Email Address
Overview
Founded in 2006, Tyrogenex is comprised of an experienced team that is dedicated to advancing next generation targeted therapeutics as promising new treatments to improve the lives of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Chris Liang
VP - Operations
Kimberly Harrow
Browse more venture capital transactions:
Prev: 2/29/2016: VitalWare venture capital transaction
Next: 2/29/2016: Regroup Therapy venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs